Skip to main content

Division of Hematology & Oncology

Advance cancer and blood disorder discovery and care alongside expert clinicians and researchers shaping innovative treatments and training the next generation of leaders.

At the forefront of cancer research, the MUSC Hollings Cancer Center (HCC) is one of 73 National Cancer Institute-designated cancer centers in the nation and the only one in South Carolina. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public and to establish outreach services for underserved populations across the state.

As an integral component of the Hollings Cancer Center, the MUSC Division of Hematology & Oncology builds upon a long history of excellence in hematology and hematological malignancies, as well as solid tumor oncology and bone marrow transplant. Division faculty are leaders in the fields of cancer care and blood disorders. In the latest rankings by U.S. News & World Report, MUSC Health's Hematology/Oncology program ranked as high-performing for the treatment of cancer.

Leading Progress in Cancer and Hematologic Medicine

The division’s fellowship program continues to recruit top tier candidates and is the only hematology oncology training program in the state of South Carolina. The program provides each fellow extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation.

Learn More

Our faculty lead pioneering research and clinical trials, expanding treatment options for cancers and blood disorders. As an NCI-Designated Cancer Center, Hollings offers exclusive therapies and trials unavailable elsewhere in South Carolina.

Learn More

As a statewide referral center, our division specializes in solid tumor oncology, malignant and benign hematology, and bone marrow transplants. With a dedicated clinical team, we provide exceptional care at Hollings Cancer Center, the Ralph H. Johnson VA Medical Center, Medical University Hospital, and Ashley River Tower.

Learn More

Latest impact in hematology and oncology

Cancer Care + Research
Clinical trial of purified CAR-T cell therapy awarded NCI grant to expand
Cancer Care + Patient Journeys
Blood and Marrow Transplant and Cellular Therapy team reaches 3,000 patient milestone
Cancer Care + Research
Hollings enrolls first patient in new bifunctional antibody cancer trial

A. Craig Lockhart, M.D., MHS, FASCO

Chief, Division of Hematology & Oncology
Associate Director of Clinical Science, Hollings Cancer Center
Professor, College of Medicine

A. Craig Lockhart, M.D., MHS, FASCO, is Chief of the Division of Hematology & Oncology in the MUSC Department of Medicine and Associate Director of Clinical Science at Hollings Cancer Center. With over 20 years of experience conducting clinical trials, a key part of his role as Associate Director is facilitating efforts to bring scientific discoveries from Hollings' laboratories into clinical application through clinical trials.

mail lockhara@musc.edu View Faculty Profile open_in_new View Provider Profile open_in_new View Research Profile open_in_new

Contact Our Division

MSC 635
Walton Research Building
39 Sabin St
Charleston, SC 29425

Main: 843-792-4271

Fax: 843-792-0644

Get Directions